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During embryonic development, multiple signaling pathways control specification, migration, and differentiation of
the vascular endothelial cell precursors, angioblasts. No single gene responsible for the commitment of mesenchymal
cells to the angioblast cell fate has been identified as yet. Here we report characterization and functional studies of
Etsrp, a novel zebrafish ETS domain protein. etsrp embryonic expression is only restricted to vascular endothelial cells
and their earliest precursors. Morpholino knockdown of Etsrp protein function resulted in the complete absence of
circulation in zebrafish embryos. Angioblasts in etsrp–morpholino-injected embryos (morphants) failed to undergo
migration and differentiation and did not coalesce into functional blood vessels. Expression of all vascular endothelial
molecular markers tested was severely reduced in etsrp morphants, whereas hematopoietic markers were not affected.
Overexpression of etsrp RNA caused multiple cell types to express vascular endothelial markers. etsrp RNA restored
expression of vascular markers in cloche mutants, defective in hematopoietic and endothelial cell formation, arguing
that etsrp functions downstream of cloche in angioblast formation. etsrp gene function was also required for
endothelial marker induction by the vascular endothelial growth factor (vegf) and stem cell leukemia (scl/tal1). These
results demonstrate that Etsrp is necessary and sufficient for the initiation of vasculogenesis.
Citation: Sumanas S, Lin S (2006) Ets1-related protein is a key regulator of vasculogenesis in zebrafish. PLoS Biol 4(1): e10.
Introduction
Vasculogenesis, or formation of vascular endothelial cells
de novo, begins very early after the initiation of gastrulation
in a vertebrate embryo. In a mammalian embryo, vasculo-
genesis starts with the formation of the blood islands in the
yolk sac and angioblast precursors in the head mesenchyme
[1]. In the zebraﬁsh, the ﬁrst angioblasts arise from the lateral
plate mesoderm, migrate to the trunk midline between ten-
and 15-somite stages in response to hedgehog signaling, and
coalesce to form the primary axial vessels of the trunk, the
dorsal aorta, and the cardinal vein [2–4]. During subsequent
angiogenesis, the axial vessels sprout to form secondary
vessels in the trunk region of a zebraﬁsh embryo [5]. In the
zebraﬁsh, as well as the mammalian yolk sac, there is a close
association between the primitive hematopoietic cells and the
developing endothelium, suggestive of a common precursor,
the hemangioblast [6]. Zebraﬁsh cloche mutants lack nearly all
blood and endothelial cells suggesting that the hemangioblast
lineage has been affected [7,8]. A basic helix-loop-helix
transcription factor Scl/tal1 is expressed in hematopoietic
and endothelial cells in both mouse and zebraﬁsh suggesting a
possible role in speciﬁcation of the hemangioblast [9–12].
Recent knockdown analysis has demonstrated its essential
function in blood and dorsal aorta formation in zebraﬁsh
embryos [13,14].
Members of the Ets family of transcription factors play
multiple roles during vasculogenesis, angiogenesis, and
hematopoiesis [15]. They share a conserved DNA-binding
domain of 85 amino acids which folds into a winged helix-
turn-helix motif. Ets1, the founding member of the family, is
expressed in the embryonic endothelial cells as well as
putative hemangioblasts, lymphoid precursors, and myeloid
hematopoietic cells [16–19]. The expression of Ets1 tran-
scripts is associated in vivo with the activation of endothelial
cells and the induction of angiogenesis. In vitro, Ets1 is
expressed by proliferating and migrating endothelial cells but
not after these cells have reached conﬂuence [20,21]. In
endothelial cells in vitro, Ets1 has been shown to regulate
expression of the two vascular endothelial growth factor
(Vegf) receptors Flt1 and Flk1 [22,23], the endothelial cell-
speciﬁc adhesion protein VE-cadherin [24], the vascular-
speciﬁc tyrosine kinases Tie1 and Tie2 [25], and numerous
other target genes [15]. Ets1 antisense oligonucleotides
inhibited angiogenesis in vitro [26,27]. However, no defects
in vascular development have been found in the mouse
embryos, nearly completely deﬁcient in Ets1 function [28,29].
Therefore, the function of Ets1 in vascular development in
vivo, if any, remains unclear.
A different Ets family member Fli1 has been implicated in
mouse megakaryopoiesis, hemostasis, and maintenance of
vascular integrity [30,31]. Zebraﬁsh ﬂi1 homolog is expressed
duringearlysomitogenesisintheputativehemangioblastcells,
while later being restricted to vascular endothelial cells [32].
Recently, an endothelial-cell-speciﬁc Ets1-related zebraﬁsh
protein Etsrp has been identiﬁed [33]. In the current study,
we demonstrate a critical role of Etsrp during vasculogenesis.
In the absence of Etsrp, angioblast precursors fail to migrate,
differentiate, and coalesce into functional vessels. Further-
more, ectopic expression of etsrp is sufﬁcient to induce
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PLoS BIOLOGYendothelial markers in a variety of different cell types
throughout the embryo. These results suggest that Etsrp
f u n c t i o n sa sac r i t i c a lr e gulatory gene, directing etsrp-
expressing cells to adopt vascular endothelial cell fate during
embryonic development.
Results
Etsrp Encodes a Novel Ets1-Related Protein
A novel Ets1-related protein Etsrp has been identiﬁed in a
recent microarray study of the zebraﬁsh cloche mutants [33].
We performed detailed analysis of the protein sequence and
its developmental expression pattern. Etsrp-predicted pro-
tein sequence contains 366 amino acids and displays 29%
identity (37% similarity) to the human Ets1 protein and 26%
identity (34% similarity) to the human Ets2 (Figure 1A)
(unpublished data). Although Etsrp and hEts1 proteins are
88% similar within the ETS domain region (Figure 1A), there
is little similarity between the two proteins within the rest of
the sequence, therefore Etsrp may not be a functional
ortholog of the Ets1 protein. Supporting this idea, a recently
published protein sequence of the zebraﬁsh, Ets1 homolog,
was found to be highly similar to the Ets1 subfamily
throughout most of the protein sequence (Figure 1A) [34].
No other homology domains were found outside the ETS
domain of Etsrp. We were unable to ﬁnd an apparent Etsrp
ortholog in other species. As evident from the homology tree,
Figure 1. Sequence Analysis of the Zebrafish Ets1-Related Protein Etsrp
(A) Shows alignment of Etsrp and its closest human and zebrafish homologs Ets1 proteins. Etsrp and hEts1 share 88% homology within the ETS DNA-
binding domain (underlined in red), and a very limited homology within the rest of the sequence. Identical and similar amino acids are shaded in grey.
(B) The homology tree of Etsrp and its closest human, mouse, and zebrafish homologs. Length of horizontal branches is directly proportional to the
evolutionary distance between the proteins. Zebrafish Ets1 and Ets2 protein sequences have been predicted using the available EST sequences
TC282499 and TC270146 (http://www.tigr.org). GeneWorks 2.5 has been used to build the alignment and the homology tree. (C) Chromosomal location
of the zebrafish etsrp, mouse, and human ets1 genes. In all cases, they are positioned next to a fli1 homolog.
DOI: 10.1371/journal.pbio.0040010.g001
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Zebrafish Etsrp Regulates VasculogenesisEtsrp is the most closely related to Ets1 and Ets2 subfamilies
(Figure 1B). We performed synteny analysis of human, mouse,
and zebraﬁsh ets1 or etsrp chromosomal regions. Human and
mouse ets1 genes are positioned next to ﬂi1 genes, which
encode related ETS domain proteins (Figure 1C). ets1 and ﬂi1
genes are transcribed in opposite directions and are likely to
have originated from the same ancestral precursor via gene
duplication. Zebraﬁsh etsrp is also positioned in the opposite
direction and next to a ﬂi1-related gene ﬂi1b [34]. This
analysis suggests that etsrp is evolutionarily related to the
mammalian ets1 genes. As the zebraﬁsh genome has under-
gone an additional duplication [35], etsrp and ets1 may have
diverged from each other and acquired separate functions.
Alternatively, it is possible that ets1 duplicated prior to the
divergence of teleosts and tetrapods, and etsrp was subse-
quently lost in the tetrapod lineage.
Etsrp Expression Pattern Analysis
We analyzed the expression pattern of etsrp RNA in early
embryos using in situ hybridization. No expression was
observed prior to the one-somite stage (unpublished data).
From the two-somite stage onward, etsrp RNA was localized to
two stripes of cells within the lateral mesoderm (ﬁve-somite
embryo, Figure 2A). Two distinct expression domains, in the
anterior and posterior parts of an embryo, were apparent.
The anterior stripes merged at the prechordal plate. The
etsrp-expressing cells are likely endothelial cell precursors
based on the expression of the gene at later stages. At the 15-
somite stage, expression in two bilateral stripes of cells within
the lateral mesoderm in the anterior and middle/posterior
parts of an embryo, was apparent (Figure 2B–2D). In addition,
a stripe of etsrp-expressing cells was noted at the midline and
extended through the trunk and posterior parts of an embryo.
The middle stripe likely represents the endothelial precursor
cells that have already migrated to the future intermediate
cell mass (ICM) region. By 26 hours-post-fertilization (hpf),
etsrp was expressed in vascular endothelial cells in the embryo
marking main axial, head, and intersegmental vessels (Figure
2E). In addition, a group of etsrp-expressing cells was located
in the intermediate mesoderm region (Figure 2E and 2F).
These cells which by 36 hpf were located close to the
pronephros (Figure 2G), and appeared to migrate posteriorly,
may represent endothelial cell precursors of pronephric
vessels and/or gut vessels. By 36 hpf etsrp expression had
mostly disappeared from the axial vessels and was prominent
in a subset of head vessels, aortic arches, the cardinal vein
plexus region, posterior intersomitic vessels, and the dorsal
longitudinal anastomotic vessel (Figure 2G). At 52 hpf, etsrp
expression was observed in a subset of head vessels, the
common cardinal vein, blood vessels of the pectoral ﬁn, the
cardinal vein plexus region, and weakly in posterior inter-
segmental vessels and the dorsal vessel (Figure 2H).
Morpholino Knockdown of Etsrp Function Results in Loss
of Circulation
We used antisense morpholino (MO) oligonucleotides
[36,37] to knockdown the function of Etsrp. Etsrp–MO-
injected embryos (morphants) showed no apparent circula-
tion. While red blood cells were actively circulating in wild-
type (wt) embryos at 34 hpf, in etsrp morphants they stayed at
their formation site, the ICM region (Figure 3A and 3B). This
observation was conﬁrmed by the o-dianisidine staining of
heme in the red blood cells (Figure 3C–3E). We performed
microangiography analysis by injecting ﬂuorescein-labeled
high molecular weight dextran into the sinus venosus of the
2-day-old embryos. Lower doses of etsrp MOs caused partial
loss of circulation in the intersegmental and axial vessels,
particularly, in the posterior part of the embryo (Figure 3F
and 3G). Head circulation was not affected at this dose
(Figure 3G). Higher doses of etsrp MOs resulted in the
complete loss of functional blood vessels (Figure 3H and 3I,
Table 1). Other than the described defects, etsrp morphants
appeared morphologically normal (Figure 3B). At 2–3 days-
post-fertilization (dpf), etsrp morphants developed pericar-
dial edema and eventually became necrotic and died
(unpublished data). Injection of two different etsrp-speciﬁc
Figure 2. Expression Pattern of etsrp as Analyzed by In Situ Hybridization
Anterior is to the left except as noted. (A) five-somite stage. etsrp is expressed within lateral mesoderm in two distinct expression domains, in the
anterior and posterior parts of an embryo. (B) 15-somite stage, lateral view. (C) dorsal view. (D) transverse section. etsrp is expressed in two bilateral
stripes of presumptive angioblasts within the lateral mesoderm in the anterior and the trunk and posterior parts of an embryo (arrows, D). In addition,a
stripe of etsrp-expressing cells is apparent at the midline and extends through the middle and posterior parts of an embryo (arrowhead, C and D). (E) 26
hpf stage. etsrp is expressed in vascular endothelial cells of the axial, head, and intersomitic vessels. Note a group of etsrp-expressing cells bilaterally
located in the intermediate mesoderm (arrowhead). (F) Transverse section through the trunk region of a 30 hpf embryo. Arrowhead shows one of the
etsrp-expressing cells located within the lateral/intermediate mesoderm. Expression of etsrp in the axial vessels is weak at this stage and not apparent in
this section. nt, neural tube; n, notochord; y, yolk. (G) 36 hpf stage. etsrp is expressed in a subset of head vessels, the aortic arches (aa), the cardinal vein
plexus (pl) region, posterior intersomitic vessels, and the dorsal longitudinal anastomotic vessel (dlav). Note a group of etsrp-expressing cells located in
the endodermal region (arrowhead). (H) 52 hpf stage. etsrp expression is observed in a subset of head vessels, common cardinal vein, pectoral fin bud
blood vessels (fb), cardinal vein plexus region, and weakly in posterior intersegmental vessels and the dorsal vessel.
DOI: 10.1371/journal.pbio.0040010.g002
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Zebrafish Etsrp Regulates VasculogenesisFigure 3. MO Knockdown of Etsrp Protein Function Disrupts Blood Vessel Formation in the Zebrafish Embryos
(A,B) Morphological analysis of live etsrp morphants at 34 hpf. (A) Uninjected control embryo. (B) 5 ng of etsrp MO1-injected embryo. Notice that red
blood cells are scattered throughout the circulatory system in the control uninjected embryo while they accumulate at their formation site within the
intermediate cell mass (arrow, B) in the etsrp morphant. (C–E) o-dianisidine staining of heme in the red blood cells of uninjected control (C), 5 ng of etsrp
MO1-injected (D) and 5 ng of etsrp MO2-injected (E) embryos at 34 hpf. While many circulating blood cells are apparent within the common cardinal
vein before entering the heart in the control embryo (arrow, C), they stay at their formation site within the ICM region in etsrp morphants (arrows). (F–I)
Microangiography analysis of the circulatory system by injecting fluorescein-labeled dextran into the sinus venosus of etsrp morphants at 55 hpf. (F)
Control uninjected, (G) 1 ng of etsrp MO1-injected (H) 2.5 ng of etsrp MO1-injected (I) 5 ng of etsrp MO1-injected embryos. Note that the embryo in (G)
has lost circulation in the posterior vessels, the embryo in (H) has lost circulation in most vessels, and the embryo in (I) has no circulation at all. (J–M)
Analysis of blood vessels in live flk1-GFP transgenic embryos at 26 hpf. (J) Control uninjected, (K) 1 ng of etsrp MO1-injected, (L) 2.5 ng of etsrp MO1-
injected, (M) 15 ng of etsrp MO1þMO2 (1:1) mix-injected embryos. Note the gaps in formation of intersegmental vessels in (K) (arrowhead), the missing
(arrowhead) and abnormally branched, (arrow) intersegmental vessels in (L), and the nearly completely eliminated flk1 expression from axial vessels
(arrow) in (M).
DOI: 10.1371/journal.pbio.0040010.g003
Table 1. Dose Dependence of Etsrp MO Phenotype
Dose
Injected
Normal Circulation,
% of Embryos
No or Defective Intersegmental
Circulation, % of Embryos
No Intersegmental and No or
Defective Axial, % of Embryos
Complete Loss of Circulation,
% of Embryos
1–1.5 ng MO1 62 6 17 27 6 16 7 6 31 6 1
2.5 ng MO1 19 6 63 4 6 94 2 6 81 6 1
5–6 ng MO1 9 6 33 5 6 93 5 6 10 22 6 3
1 ng MO2 4 6 17 6 46 3 6 11 27 6 5
2.5 ng MO2 6 6 34 6 14 7 6 44 0 6 11
5–6 ng MO2 4 6 45 6 51 8 6 17 1 6 11
Two different etsrp-specific translation-blocking MOs cause the same phenotype, resulting in defective intersegmental and axial circulation at lower doses and complete loss of circulation at higher doses. Live embryos were scored at 2 dpf by
visual observation.
DOI: 10.1371/journal.pbio.0040010.t001
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Zebrafish Etsrp Regulates Vasculogenesistranslation-blocking MOs resulted in similar circulatory
defects, demonstrating speciﬁcity of the observed phenotype
(Table 1). To conﬁrm that etsrp MOs were speciﬁcally
inhibiting synthesis of Etsrp protein, we generated etsrp–
green ﬂuorescent protein (GFP) modiﬁed bacterial artiﬁcial
chromosome (BAC). BAC construct of approximately 250
kilobases containing etsrp gene was modiﬁed using recA-
mediated homologous recombination to replace etsrp coding
sequence with GFP [38]. Microinjection of etsrp-GFP BAC
resulted in the mosaic GFP expression (Figure S1A). Etsrp
MO2, directed against the 59 UTR of etsrp,c o m p l e t e l y
inhibited this transient GFP expression (Figure S1B). Control
injection of a 5-base mismatch MO had no effect on GFP
expression (Figure S1C). These results conﬁrm that etsrp MOs
speciﬁcally inhibit etsrp gene function. Microinjection of a
low dose of etsrp MO into ﬂk1-GFP transgenic embryos [39]
resulted in partial loss of ﬂk1 expression in intersegmental
vessels (Figure 3J–3L). High doses of etsrp MOs resulted in
nearly complete loss of ﬂk1 expression in axial vessels and
strong downregulation of its expression in head vessels
(Figure 3M).
Vascular Endothelial Markers Are Lost in Etsrp Morphants
We performed analysis of different molecular markers in
etsrp morphants using high doses of etsrp MOs. Kinase insert
domain receptor (kdr, ﬂk1) [40], cadherin 5 (cdh5, VE-cadherin) [41],
adrenomedullin receptor (admr) [42], dual speciﬁcity phosphatase 5
(dusp5) [42], and C1qR-like (crl) [42] genes are expressed in all
vascular endothelial cells while fms-related tyrosine kinase 4 (ﬂt4)
[40] is restricted to the venous vessels in early zebraﬁsh
embryos. Expression of all of these markers in axial and
intersegmental vessels was nearly completely abolished in
etsrp morphants at 24 hpf (Figure 4A–4L). Head vessel
expression, however, was reduced but still apparent even at
high MO doses (Figure 4A–4D) (unpublished data). We were
unable to use even higher MO doses to attempt to completely
eliminate Etsrp function due to mild toxic effects observed at
doses above 15 ng (unpublished data).
Expression of friend leukemia integration 1 (ﬂi1) [40] was
downregulated but still apparent in etsrp morphants (Figure
4M and 4N). Interestingly, expression of etsrp itself was
upregulated in etsrp morphants, suggesting the presence of a
negative autoregulatory loop (Figure 4O and 4P). However,
the number of etsrp-expressing angioblasts was reduced in
etsrp morphants. These angioblasts remained scattered within
the lateral mesoderm failing to coalesce into functional blood
vessels (Figure 4P). Formation of hematopoietic precursors
appeared unaffected as evident from scl and gata1 expression
(Figure 4Q–4T).
We analyzed formation of hematopoietic and vascular
progenitors during early somitogenesis stages. A transcrip-
tion factor scl is expressed in both hematopoietic and
vascular endothelial cell precursors [12]. Expression of scl in
etsrp morphants was reduced in the anterior domain and
absent from the trunk domain while its posterior expression
was not affected at the six- and ten-somite stages (Figure 5A–
5D). ﬂi1 is expressed in the putative hemangioblast cells while
later being restricted to vascular endothelial cells [32].
Anterior expression of ﬂi1 was absent in etsrp morphants
while its tail expression was not affected at the six-somite
stage (Figure 5E and 5G). At the ten-somite stage, ﬂi1
expression in etsrp morphants was absent from the anterior
and trunk domains (Figure 5F and 5H). As described earlier,
angioblasts migrate from the lateral mesoderm towards the
Figure 4. Molecular Analysis of Vascular Endothelial and Hematopoietic Markers in etsrp Morphants
(A, C, E, G, I, K, M, O, Q, S) Uninjected control embryo; (D, H, J, L, P, R, T) 8 ng etsrp MO2-injected embryo; (B, F, N) 12 ng etsrp MO1þMO2 (1:1) mix-
injected embryos for the maximum knockdown. All embryos are at 24 hpf, except as noted. Scale bar, 0.2 mm. (A,B) flk1 expression; (C,D) admr
expression; (E,F) cdh5 expression; (G,H) dusp5 expression; (I,J) flt4 expression; (K,L) crl expression. Note that the vascular expression of the markers in (A–
L) is almost absent in etsrp morphants. (M,N) fli1 expression; (O,P) etsrp expression. Note the more intense etsrp expression and reduced fli1 expression
in angioblasts which remain dispersed and fail to coalesce into blood vessels in etsrp morphants. Inset, (P) DIC image of scattered angioblasts in etsrp
morphants. (Q,R) scl expression, 22 hpf. Note that scl expression appears unaffected at this stage except for more intense staining in a subset of head
vessels in etsrp morphants (arrowhead). (S,T) gata1 expression, 22 somites. Note that no significant difference in hematopoietic gata1 expression is
observed between the control embryos and etsrp morphants.
DOI: 10.1371/journal.pbio.0040010.g004
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Zebrafish Etsrp Regulates Vasculogenesismidline during somitogenesis [2,3]. etsrp-expressing angio-
blasts were present within the lateral mesoderm but failed to
migrate towards the midline in etsrp morphants (Figure 5I–
5L). Also, no scl-o rﬂi1-expressing migrating angioblasts were
observed in etsrp morphants (unpublished data). etsrp ex-
pression level within the angioblasts was strongly increased in
etsrp morphants suggesting the presence of negative autor-
egulation. All of the etsrp-expression domains, including the
trunk domain, were present in etsrp morphants (Figure 5I–5L)
(unpublished data).
Etsrp is Sufficient for the Vascular Endothelial Marker
Induction
We analyzed if etsrp mRNA was sufﬁcient for induction of
the vascular endothelial markers. Injection of synthetic etsrp
mRNA into zebraﬁsh embryos at the 1–16 cell stage resulted in
strong ectopic induction of vascular endothelial markers ﬂk1,
scl, ﬂi1, and cdh5 during somitogenesis (Figure 6A–6F)
(unpublished data). Large patches of intense ectopic ﬂk1
expression were observed within different germ layers
including dorsal, lateral, and ventral mesoderm, endoderm
and neuroectoderm (Figure 6E and 6F) (unpublished data). No
induction of hematopoietic marker gata1 was observed (Figure
6G and 6H). These results indicate that etsrp is sufﬁcient to
induce vascular endothelial gene expression in a variety of cell
types. Furthermore, etsrp speciﬁcally induces vascular markers
without affecting closely related hematopoiesis.
Wetestedifetsrpwassufﬁcientforvascularinductioninclo / 
mutant embryos. etsrp mRNA was injected into the progeny
from cloþ/  carriers, and the embryos were analyzed for ﬂk1
expressionattheten-to12-somitestages.Asexpected,25%(23
out of 92) of the uninjected progeny from cloþ/  carriers
showed no ﬂk1 expression. Among etsrp mRNA injected
embryos (n ¼ 110), 29% displayed normal ﬂk1 expression
pattern(withminordistortionsinsomeembryos),45%showed
bothendogenousandectopicﬂk1expression,19%showedonly
ectopic ﬂk1 expression, and 6% showed no detectable ﬂk1
expression (Figure 6I–6L). The last two groups apparently
represent clo / homozygous mutants. These results show that
the induction of ﬂk1 by etsrp is independent of clo function,
suggesting that etsrp functions downstream of clo. etsrp mRNA
did not fully restore the endogenous pattern of ﬂk1 expression
in clo /  mutants most likely because it was expressed
ubiquitously and not localized to vascular progenitors.
Etsrp Function Is Required for flk1 Induction by Vegf and
Scl
We analyzed the epistatic relationship between vegf and
etsrp. vegf overexpression has been reported to induce strong
expression of vascular markers such as ﬂk1 [43] (Figure 7A
Figure 5. Molecular Analysis of Early Vasculogenesis in etsrp Morphants
(A, B, E, F, I, K) Uninjected control embryo; (C, D, G, H, J, L) 8–10 ng etsrp MO2-injected embryo. Anterior is to the left in all panels. (A–H) Embryos were
flat mounted with their yolk removed. (A–D) scl expression; six-somite (A,C) and ten-somite (B,D) stages. Note that the anterior domain of scl expression
(arrows) is reduced and the trunk domain (arrowheads) is missing in etsrp morphants. (E–H) fli1 expression; six-somite (E,G) and ten-somite (F,H) stages.
Note that the anterior domain of fli1 expression (arrows) is missing in the etsrp morphants, while the posterior domain is not affected. Also note that the
trunk domain of fli1 expression (arrowheads, F,H) is missing at the ten-somite stage in etsrp morphants. (I–L) Etsrp knockdown blocks angioblast
migration towards the midline as assayed by etsrp expression at the 16-somite (I,J) and 20-somite (K,L) stages. (I,K) Uninjected control embryo; (J,L) 7.5
ng etsrp MO2-injected embryo. Dorsal view, anterior is to the left. Note that the midline stripe of angioblasts (arrows) is missing in etsrp morphants. Also
notice more intense etsrp expression in pre-migratory angioblasts (arrowheads) in etsrp morphants as compared to control embryos.
DOI: 10.1371/journal.pbio.0040010.g005
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Zebrafish Etsrp Regulates Vasculogenesisand 7B). Co-injection of vegf mRNA together with etsrp MO
resulted in the loss of ﬂk1 expression, similar to etsrp MO
phenotype, indicating that etsrp function is required for ﬂk1
induction by vegf signaling (Figure 7C and 7D). Down-
regulation of vegf expression resulted in the loss of etsrp
expression in the intersegmental vessels (Figure 7E and 7F).
etsrp expression in dorsal aorta was also not apparent while
cardinal vein seemed expanded. This is consistent with the
previous report of vegf involvement in regulating arterial
fate in zebraﬁsh [44]. Expression of etsrp was not affected in
vegf morphants during mid-somitogenesis stages (unpub-
lished data).
Scl has been implicated in the hematopoietic and vascular
development in zebraﬁsh [13,14]. Downregulation of Scl
function using two different MOs had no signiﬁcant effect
on the etsrp expression in angioblasts while the hematopoietic
expression of gata1 was completely eliminated (Figure 7G–7J).
Overexpression of scl mRNA has been reported to cause
induction of vascular markers [45]. We tested if etsrp MO
would block this induction by co-injecting it together with scl
mRNA. The embryos were analyzed for ﬂk1 expression at the
15-somite stage (Figure 7K–7N). As expected, no or only
extremely weak ﬂk1 expression was observed in etsrp–MO-
injected embryos (Figure 7L). Overexpression of scl mRNA
caused strong induction of ﬂk1 (Figure 7M). Embryos, co-
injected with scl mRNA and etsrp MO showed no or very weak
ﬂk1 expression (Figure 7N). These results demonstrate that
etsrp function is required for ﬂk1 induction by scl.
Discussion
In this study, we report characterization and functional
analysis of a novel zebraﬁsh Ets1-related protein, Etsrp.
Knockdown of Etsrp resulted in the complete absence of
functional blood vessels and downregulation of all endothe-
lial-speciﬁc markers analyzed. In zebraﬁsh, hedgehog signaling
is necessary for migration of angioblasts from the lateral
mesoderm toward the midline, where they subsequently
differentiate within the ICM region [4]. Such migration is
not apparent in the anterior region which gives rise to the
anterior vessels including head vessels. Interestingly, vasculo-
genesis defects in etsrp morphants were more pronounced in
the posterior region of the embryo which was particularly
evident at lower downregulation levels. At high MO doses,
endothelial cells were nearly completely absent from axial
and intersegmental vessels. However, head expression of
endothelial markers was not completely eliminated. It is
possible that the remaining amount of Etsrp protein activity
is sufﬁcient for the head vasculogenesis. Upregulation of etsrp
RNA was particularly strong in the head region in etsrp
morphants, which may partially compensate for the MO-
mediated translation inhibition. Alternatively, etsrp function
may be redundant in the vasculogenesis of head vessels.
Among the vascular-speciﬁc genes analyzed, expression of
only ﬂi1 and scl was not globally downregulated in the early
embryos. The early ﬂi1 expression, which overlaps with the
hematopoietic factor gata2 expression, is unaffected in the clo
mutants and scl morphants and has been suggested to mark
Figure 6. etsrp RNA Overexpression Induces Ectopic Expression of Vascular Endothelial Markers
Dorsal view, anterior to the left in all panels except for (E,F) which are lateral views. (A, C, E, and G) Control uninjected embryo; (B, D, F, and H) 100 pg of
etsrp RNA-injected embryo. (A,B) scl expression at the eight-somite stage; (C,D) flk1 expression at the nine-somite stage. Note the strong ectopic
induction of scl and fli1 upon overexpression of etsrp RNA. (E,F) Live flk1-GFP embryo at the 14-somite stage; fluorescent and transmitted light images
were overlayed. Note the very strong ectopic induction of GFP expression in different tissues including neuroectoderm (arrow, F) upon etsrp RNA
overexpression. Fluorescence in the control uninjected flk1-GFP embryo in (E) is not detectable under the same exposure. (G,H) gata1 expression at the
16-somite stage. Note that gata1 expression is not affected upon etsrp overexpression. (I–L) etsrp RNA induces flk1 expression in clo mutant embryos as
analyzed using flk1 probe at the ten- to 12-somite stages. (I) wt (or cloþ/ ) embryo, (J) wt (or cloþ/ ) embryo injected with 100 pg of etsrp RNA, (K)
clo /  embryo, (L) clo / embryo injected with 100 pg of etsrp RNA. Note that in a cloþ/  (or wt) embryo etsrp RNA induces ectopic flk1 (arrow, J) in
addition to the endogenous flk1 expression (arrowheads, J) while clo-/  etsrp RNA-injected embryo shows only ectopic flk1 (arrows, L).
DOI: 10.1371/journal.pbio.0040010.g006
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[13,32]. ﬂi1 is later expressed speciﬁcally in the vascular
endothelial cell precursors, and this expression was reduced
but not completely eliminated in etsrp morphants. ﬂi1
expression may not be directly regulated by etsrp, therefore
undifferentiated angioblasts retain some of ﬂi1 expression in
etsrp morphants. scl is expressed in both hematopoietic and
vascular progenitors throughout most of the early develop-
ment. Although we did not see global downregulation of scl
expression in etsrp morphants, it is likely that scl expression is
lost in angioblasts but retained in hematopoietic precursors.
Interestingly, expression of both ﬂi1 and scl genes was lost
from the anterior and trunk domains of the lateral
mesoderm. Anterior domain contains angioblast and myeloid
progenitors, which appear to be absent from the etsrp
morphants. The difference between the trunk and posterior
lateral mesoderm has not been previously analyzed in great
detail. Possibly, the trunk region contains mostly angioblasts,
while the tail region contains both angioblasts and hema-
topoietic precursors.
Overexpression of etsrp induced strong ectopic expression
of vascular markers in multiple cell types, including even
tissues that normally commit to a very different fate such as
neuroectoderm. Furthermore, overexpression of etsrp specif-
ically initiated vascular development without affecting
related hematopoiesis, which argues that the observed effects
are not caused by an early ventralization of the whole
embryo. These results indicate that etsrp is sufﬁcient to
initiate vasculogenesis. As a contrast, overexpression of other
regulators of vasculogenesis such as vegf and scl induced
expression of vascular markers only within the lateral or
somitic mesoderm [14,43,45].
Figure 7. etsrp Is Required for vegf and scl Signaling
(A–D) Etsrp is required for Vegf signaling as assayed for flk1 expression at 26 hpf. (A) Control uninjected embryo, (B) vegf RNA-injected embryo, (C) 7.5
ng of etsrp MO2-injected embryo, (D) vegf RNA- and etsrp MO2-co-injected embryo. Note that vegf RNA induces strong flk1 expression in (B) while vegf
RNA and etsrp MO co-injection results in loss of flk1 expression in (D), similar to the etsrp morphant phenotype in (C). (E,F) Etsrp expression analysis in
Vegf morphants at 26 hpf. (E) Control uninjected embryo; (F) 10.5 ng of vegf MO-injected embryo. Note that vegf morphants have lost etsrp expression
in the intersegmental vessels (arrowhead, E). (G–J) Scl knockdown affects gata1 but not etsrp expression at the 15-somite stage. Dorsal view, anterior is
to the left. (G,I) Control uninjected embryo; (H,J) 10 ng scl UTR-MO-injected embryo. (G,H) gata1 expression; (I,J) etsrp expression. (K–N) Etsrp is required
for scl signaling in clo mutants as analyzed for flk1 expression at the 15-somite stage. (K) Control uninjected embryo; (L) 7.5 ng etsrp MO2-injected
embryo; (M) scl RNA-injected embryo; (N) scl RNA- and etsrp MO2-co-injected embryo. Note that scl RNA causes ectopic flk1 expression in (M) which is
lost upon knockdown of Etsrp in (N).
DOI: 10.1371/journal.pbio.0040010.g007
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vascular development in the absence of etsrp function, which
suggests that etsrp is an essential mediator of vegf and scl
signaling, at least in the vascular induction. Loss of vegf or scl
did not affect early expression of etsrp within angioblasts.
Overexpression of etsrp caused strong scl induction, indicat-
ing that etsrp plays an important role in controlling scl
expression, at least within angioblasts. This is also supported
by the loss of scl expression in the anterior and trunk regions
in etsrp morphants. Our data suggest that etsrp is necessary for
scl expression within angioblasts, and both genes are then
required for induction of multiple vascular endothelial genes.
The current study shows for the ﬁrst time that a single gene
can be necessary and sufﬁcient for initiating vascular
development in vertebrates. Our results demonstrate that
Etsrp acts as a very early regulator of vasculogenesis. These
ﬁndings will greatly advance our understanding of vascular
development and the general mechanisms of cell fate
speciﬁcation.
Materials and Methods
Microinjection of MOs. Two etsrp-speciﬁc MOs (MO1, TTGGTA
CATTTCCATATCTTAAAGT and MO2, CACTGAGTCCTTATTT
CACTATATC; Gene Tools, Inc.) were used to inhibit the function
of Etsrp protein. For the dose response curve, 1–6 nl of 1 mg/ml MO
solution in the Danieau buffer supplemented with 15 mM Tris-Cl (pH
7.5) was injected into one- to two-cell-stage embryos [36]. For
phenotypic and marker analysis, 3–4nl of 2.5 mg/ml MO2 solution was
injected. A ﬁve-base MO2 mismatch (CAGTGAGACCTTAATTCAG
TATAAC) was used as a control MO. A previously described Vegf-A-1
MO (kindly donated by S.C. Ekker) was used to inhibit Vegf function
[46]. Scl translation-blocking UTR-MO (GCTCGGATTT
CAGTTTTTCCATCAT) and previously described splice-blocking
MO [13] were used to inhibit the function of Scl protein. Micro-
injections were performed as described [47].
BAC modiﬁcation and microinjection. CHORI-211 BAC library
from Children’s Hospital Oakland Research Institute, Oakland,
California, United States was used to identify etsrp-containing–BAC
of approximately 250 kilobases. Replacement of Etsrp coding
sequence with GFP was essentially performed as described [38].
Puriﬁed BAC DNA (100–150 pg) was injected into blastomere at the
one-cell stage.
RNA overexpression and epistasis experiments. Etsrp overexpres-
sion construct was generated by subcloning the open reading frame
of etsrp into the SpeI site of pT3TS [47]. To synthesize mRNA, Etsrp-
T3TS was linearized with XbaI and transcribed using T3 mMessage
mMachine Kit (Ambion, Austin, Texas, United States). At the two- to
16-cell stage for overexpression studies, 75–15 pg of etsrp mRNA was
injected into zebraﬁsh embryos. For epistasis studies, approximately
50 pg of VEGF121 and VEGF165 mRNA 1:1 mixture was injected [43].
Approximately 300 pg of scl mRNA was injected for epistasis studies
[12].
In situ hybridization. In situ hybridization was performed as
described [48]. The following probes were used: etsrp [42], ﬂk1 [40], ﬂi1
[40], ﬂt4 [40], scl [12], gata1 [49], admr [42], cdh5 [42], crl [42].
Analysis of etsrp knockdown phenotype. o-dianisidine heme
staining was performed as described [49]. Microangiography was
performed as described [46].
Zebraﬁsh strains. Majority of etsrp knockdown analysis was
performed in the wild-type zebraﬁsh from Scientiﬁc Hatcheries
(Huntington Beach, California, United States). As conﬁrmed by
sequencing, no polymorphisms in the etsrp MO-binding sites were
detected in this wild-type strain. In addition, ﬂk1-GFP transgenic
zebraﬁsh line was used [39]. clo
m39 line was used in etsrp over-
expression experiments [7].
Supporting Information
Figure S1. Etsrp MO Blocks GFP Expression in the Embryos Injected
with etsrp–GFP-Modiﬁed BAC Construct
Mosaic panels have been generated by taking individual images of
randomly chosen embryos from each batch. Embryos are at the 90%
epiboly stage. (A) Following microinjection, etsrp-GFP BAC is
transiently expressed in a mosaic pattern. Note that the transient
BAC expression commonly does not recapitulate the endogenous
expression pattern. (B) Co-injection of etsrp-GFP BAC and 10 ng of
etsrp MO2 completely eliminated GFP ﬂuorescence. (C) Co-injection
of etsrp-GFP BAC and 10 ng of 5-base MO2 mismatch had no effect on
GFP ﬂuorescence.
Found at DOI: 10.1371/journal.pbio.0040010.sg001 (2.5 MB TIF).
Accession Numbers
GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession number
for etsrp is DQ021472.
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